• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯疱疹病毒1型复制缺陷型突变体的免疫机制。

Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.

作者信息

Morrison L A, Knipe D M

机构信息

Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Virology. 1996 Jun 15;220(2):402-13. doi: 10.1006/viro.1996.0328.

DOI:10.1006/viro.1996.0328
PMID:8661391
Abstract

We have investigated the mechanisms by which subcutaneous immunization of mice with a replication-defective mutant of herpes simplex virus 1 protects against infection of the eye and latent infection of the trigeminal ganglion following corneal challenge. First, we have shown that immunization reduces the number of trigeminal ganglion neurons in challenged animals that express the latency-associated transcript. This indicates that the reduction in the incidence of latent infection by challenge virus is likely due to immune mechanisms and not saturation of the potential sites of latent infection by the immunizing mutant virus itself. Second, the duration of protective immunity against acute infection, keratitis, and latent infection was similar in mice immunized with replication-defective or -competent virus; thus, the replication-defective mutant virus is able to induce durable immunity apparently without spread in the host. Third, although the mutant virus showed no evidence of replication in vivo, it was present in footpad tissue in an infectious form for several days. This surprising observation raises the possibility that continued infection events by input virus over an extended period of time may have a boosting effect on the developing immune response which could explain, at least in part, the capacity of these replication-defective mutant viruses to elicit a robust and durable immunity despite their inability to spread within the host.

摘要

我们研究了用1型单纯疱疹病毒复制缺陷型突变体对小鼠进行皮下免疫,从而在角膜激发后预防眼部感染和三叉神经节潜伏感染的机制。首先,我们发现免疫可减少受激发动物中表达潜伏相关转录本的三叉神经节神经元数量。这表明激发病毒导致的潜伏感染发生率降低可能是由于免疫机制,而非免疫突变病毒本身使潜伏感染潜在位点饱和所致。其次,用复制缺陷型或有复制能力的病毒免疫的小鼠,针对急性感染、角膜炎和潜伏感染的保护性免疫持续时间相似;因此,复制缺陷型突变病毒显然能够在不于宿主体内传播的情况下诱导持久免疫。第三,尽管突变病毒在体内未显示出复制迹象,但它以感染性形式在足垫组织中存在了数天。这一惊人发现增加了一种可能性,即输入病毒在较长时间内持续发生的感染事件可能对正在发育的免疫反应有增强作用,这至少可以部分解释这些复制缺陷型突变病毒尽管无法在宿主体内传播却仍能引发强大而持久免疫的能力。

相似文献

1
Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.单纯疱疹病毒1型复制缺陷型突变体的免疫机制。
Virology. 1996 Jun 15;220(2):402-13. doi: 10.1006/viro.1996.0328.
2
Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.抗体和T细胞亚群对1型单纯疱疹病毒复制缺陷型突变体免疫诱导的保护作用的贡献。
Virology. 1997 Dec 22;239(2):315-26. doi: 10.1006/viro.1997.8884.
3
Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.在单纯疱疹病毒2型生殖器感染小鼠模型中,不同形式的单纯疱疹复制缺陷型突变病毒作为疫苗的比较。
Virology. 2001 Sep 30;288(2):256-63. doi: 10.1006/viro.2001.1094.
4
Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.用1型单纯疱疹病毒复制缺陷型突变体进行免疫接种:在攻击病毒感染发病机制中的免疫干预位点。
J Virol. 1994 Feb;68(2):689-96. doi: 10.1128/JVI.68.2.689-696.1994.
5
Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.单纯疱疹病毒 1(HSV-1)表达突变型 ICP6 的减毒病毒可刺激强烈的免疫反应,保护小鼠免受 HSV-1 诱导的角膜疾病。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01036-18. Print 2018 Sep 1.
6
Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.复制缺陷型单纯疱疹病毒2型ICP8突变株的构建、特性鉴定及其在豚鼠生殖器疾病模型免疫研究中的应用。
Virology. 1997 May 26;232(1):1-12. doi: 10.1006/viro.1997.8564.
7
Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.单纯疱疹病毒2型复制缺陷突变株在小鼠鼻腔感染模型中的生物学特性
Virology. 2000 Dec 5;278(1):137-50. doi: 10.1006/viro.2000.0628.
8
A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.在单纯疱疹病毒1型急性和潜伏感染期间,一个非一致性分支点在决定2kb LAT内含子的稳定性方面发挥着重要作用。
Virology. 2004 Jul 1;324(2):340-9. doi: 10.1016/j.virol.2004.03.043.
9
Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice.单纯疱疹病毒UL24基因对小鼠神经节有效感染的重要性。
Virology. 1998 Mar 1;242(1):161-9. doi: 10.1006/viro.1997.9012.
10
The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.一种编码单纯疱疹病毒1型(HSV-1)糖蛋白D的DNA疫苗在减轻角膜HSV-1攻击后眼部疾病严重程度方面的疗效。
Arch Virol. 2002 Sep;147(9):1747-59. doi: 10.1007/s00705-002-0830-6.

引用本文的文献

1
Research advances in replication-deficient viral vector vaccines.复制缺陷型病毒载体疫苗的研究进展
Front Vet Sci. 2025 Mar 3;12:1535328. doi: 10.3389/fvets.2025.1535328. eCollection 2025.
2
ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice.ICP8-vhs- HSV-2 疫苗表达 B7 共刺激分子优化了针对小鼠 HSV-2 感染的安全性和疗效。
Viruses. 2023 Jul 18;15(7):1570. doi: 10.3390/v15071570.
3
A chemical method for generating live-attenuated, replication-defective DNA viruses for vaccine development.
一种用于生成活减毒、复制缺陷型 DNA 病毒的化学方法,用于疫苗开发。
Cell Rep Methods. 2022 Sep 8;2(9):100287. doi: 10.1016/j.crmeth.2022.100287. eCollection 2022 Sep 19.
4
Nanocarrier vaccines for SARS-CoV-2.用于 SARS-CoV-2 的纳米载体疫苗。
Adv Drug Deliv Rev. 2021 Apr;171:215-239. doi: 10.1016/j.addr.2021.01.002. Epub 2021 Jan 9.
5
Towards the Generation of an ASFV-pA104R DISC Mutant and a Complementary Cell Line-A Potential Methodology for the Production of a Vaccine Candidate.迈向非洲猪瘟病毒pA104R DISC突变体及互补细胞系的构建——一种生产候选疫苗的潜在方法
Vaccines (Basel). 2019 Jul 18;7(3):68. doi: 10.3390/vaccines7030068.
6
Molecular analyses and phylogeny of the herpes simplex virus 2 US9 and glycoproteins gE/gI obtained from infected subjects during the Herpevac Trial for Women.单纯疱疹病毒 2 US9 及其糖蛋白 gE/gI 的分子分析与系统进化:来自 Herpevac 女性试验感染者的研究结果。
PLoS One. 2019 Mar 8;14(3):e0212877. doi: 10.1371/journal.pone.0212877. eCollection 2019.
7
Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.单纯疱疹病毒 1(HSV-1)表达突变型 ICP6 的减毒病毒可刺激强烈的免疫反应,保护小鼠免受 HSV-1 诱导的角膜疾病。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01036-18. Print 2018 Sep 1.
8
A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.一种新型糖蛋白 D 特异性单克隆抗体中和单纯疱疹病毒。
Antiviral Res. 2017 Nov;147:131-141. doi: 10.1016/j.antiviral.2017.10.013. Epub 2017 Oct 20.
9
Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles.N-羟基异喹啉二酮及相关多氧化杂环对乙型肝炎病毒复制的抑制作用。
Antiviral Res. 2017 Jul;143:205-217. doi: 10.1016/j.antiviral.2017.04.012. Epub 2017 Apr 25.
10
The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.女性疱疹疫苗试验:对从感染受试者中分离出的病毒糖蛋白进行序列分析。
PLoS One. 2017 Apr 27;12(4):e0176687. doi: 10.1371/journal.pone.0176687. eCollection 2017.